Why the study?
Does intracoronary isosorbide dinitrate improve coronary recanalization in patients with acute myocardial infarction receiving thrombolytic therapy?
Does intracoronary isosorbide dinitrate improve coronary recanalization in patients with acute myocardial infarction receiving thrombolytic therapy?
The combination of intracoronary nitrates with thrombolytic agents promotes stable coronary recanalization by counteracting coronary constriction in acute myocardial infarction.
May support adjunctive intracoronary nitrates with thrombolysis in AMI; leaves open confirmation in randomized trials.
We have investigated the coronary vasodilator responses to nitrates in the early stages of acute myocardial infarction before, during and after the administration of thrombolytic therapy. Before thrombolysis, intracoronary doses (2-4 mg) of isosorbide dinitrate failed to induce recanalisation of the totally occluded infarct related artery. Episodes of coronary reopening and reocclusion associated with ST-segment resolution and re-elevation were frequently observed both spontaneously before and during thrombolytic therapy. In 50-86% of patients, intracoronary isosorbide dinitrate promptly re-established full coronary patency immediately after acute reocclusion or whenever coronary occlusion was incomplete, both before and during thrombolysis. After thrombolysis further intracoronary isosorbide dinitrate dilated the infarct related stenoses but not uninvolved adjacent normal coronary branches. Coronary thrombosis and constriction frequently interact during the early phases of acute myocardial infarction. The combination of high local concentrations of nitrates with thrombolytic agents promotes stable coronary recanalization and may be beneficial in patients with acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Hackett et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: